Ajooni Biotech Limited submitted a disclosure confirming no encumbrances on shares for the financial year ended March 31, 2025, under SEBI Regulation 31(4).
AI Assistant
Ajooni Biotech Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.